Metformin (Glucophage) is the most common medication used to treat type 2 diabetes (non-insulin requiring). It has been available for over 30 years and it’s beneficial effects continue to be identified.
A recent study showed that patients taking Meformin had a reduced risk of death from all causes, compared to alternative medication regimens for diabetes. This means that the medication is somehow reducing serious medical conditions ‘across the board’, including all forms of heart disease, stroke, and even cancer.
This is a very exciting finding and is consistent with other recent studies showing the multiple positive effects of Metformin.